BIOMAT Database Logo BIOMAT Database Logo

In vitro susceptibility of African isolates of Plasmodium falciparum from Gabon to pyronaridine. 1999

B Pradines, and M Mabika Mamfoumbi, and D Parzy, and M Owono Medang, and C Lebeau, and J R Mourou Mbina, and J C Doury, and M Kombila
Unité de Parasitologie, Institut de Médecine Tropicale du Service de Santé des Armées, Le Pharo, Marseille, France.

The in vitro activity of pyronaridine was evaluated against 62 isolates of Plasmodium falciparum from Libreville, Gabon using an isotopic, drug susceptibility microtest and was compared with amodiaquine, chloroquine, quinine, and halofantrine activities. The mean 50% inhibitory concentration (IC50) values of the 62 isolates from Gabon to pyronaridine was 3.0 nM (95% confidence interval [CI] = 2.1-3.9). Pyronaridine was less potent against chloroquine-resistant isolates than chloroquine-susceptible isolates but more potent than chloroquine against chloroquine-resistant parasites. The cut-off value for in vitro reduced susceptibility to pyronaridine was an IC50 > 15 nM. Two isolates (3%) showed an IC50 > 15 nM. A significant positive correlation was found between the activities of pyronaridine and chloroquine (r2 = 0.26, P < 0.001), pyronaridine and quinine (r2 = 0.36, P < 0.001), pyronaridine and amodiaquine (r2 = 0.55, P < 0.001), and pyronaridine and halofantrine (r2 = 0.50, P < 0.001). This correlation suggests in vitro cross-resistance or at least in vitro cross-susceptibility, which is not necessarily predictive of cross-resistance in vivo. The present in vitro findings require comparison with those of clinical studies.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D009287 Naphthyridines A group of two-ring heterocyclic compounds consisting of a NAPHTHALENES double ring in which two carbon atoms, one per each ring, are replaced with nitrogens.
D010616 Phenanthrenes POLYCYCLIC AROMATIC HYDROCARBONS composed of three fused BENZENE rings.
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D011803 Quinine An alkaloid derived from the bark of the cinchona tree. It is used as an antimalarial drug, and is the active ingredient in extracts of the cinchona that have been used for that purpose since before 1633. Quinine is also a mild antipyretic and analgesic and has been used in common cold preparations for that purpose. It was used commonly and as a bitter and flavoring agent, and is still useful for the treatment of babesiosis. Quinine is also useful in some muscular disorders, especially nocturnal leg cramps and myotonia congenita, because of its direct effects on muscle membrane and sodium channels. The mechanisms of its antimalarial effects are not well understood. Biquinate,Legatrim,Myoquin,Quinamm,Quinbisan,Quinbisul,Quindan,Quinimax,Quinine Bisulfate,Quinine Hydrochloride,Quinine Lafran,Quinine Sulfate,Quinine Sulphate,Quinine-Odan,Quinoctal,Quinson,Quinsul,Strema,Surquina,Bisulfate, Quinine,Hydrochloride, Quinine,Sulfate, Quinine,Sulphate, Quinine
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002738 Chloroquine The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses. Aralen,Arechine,Arequin,Chingamin,Chlorochin,Chloroquine Sulfate,Chloroquine Sulphate,Khingamin,Nivaquine,Sulfate, Chloroquine,Sulphate, Chloroquine
D005681 Gabon A republic in west equatorial Africa, south of CAMEROON and west of the CONGO. Its capital is Libreville. Gabonese Republic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

B Pradines, and M Mabika Mamfoumbi, and D Parzy, and M Owono Medang, and C Lebeau, and J R Mourou Mbina, and J C Doury, and M Kombila
In vitro susceptibility of Cambodian isolates of Plasmodium falciparum to halofantrine, pyronaridine and artemisinin derivatives.
April 1994, Annals of tropical medicine and parasitology,
B Pradines, and M Mabika Mamfoumbi, and D Parzy, and M Owono Medang, and C Lebeau, and J R Mourou Mbina, and J C Doury, and M Kombila
In vitro susceptibility of Plasmodium falciparum isolates from Abidjan, Côte d'Ivoire, to artemisinin, chloroquine, dihydroartemisinin and pyronaridine.
January 2010, Tanzania journal of health research,
B Pradines, and M Mabika Mamfoumbi, and D Parzy, and M Owono Medang, and C Lebeau, and J R Mourou Mbina, and J C Doury, and M Kombila
In Vitro Sensitivity of Pyronaridine in Thai Isolates of Plasmodium falciparum.
January 2018, The American journal of tropical medicine and hygiene,
B Pradines, and M Mabika Mamfoumbi, and D Parzy, and M Owono Medang, and C Lebeau, and J R Mourou Mbina, and J C Doury, and M Kombila
Multinormal in vitro distribution of Plasmodium falciparum susceptibility to piperaquine and pyronaridine.
February 2015, Malaria journal,
B Pradines, and M Mabika Mamfoumbi, and D Parzy, and M Owono Medang, and C Lebeau, and J R Mourou Mbina, and J C Doury, and M Kombila
Reduced in-vitro susceptibility to mefloquine in West African isolates of Plasmodium falciparum.
December 1987, Lancet (London, England),
B Pradines, and M Mabika Mamfoumbi, and D Parzy, and M Owono Medang, and C Lebeau, and J R Mourou Mbina, and J C Doury, and M Kombila
In vitro activity of mirincamycin (U24729A) against Plasmodium falciparum isolates from Gabon.
January 2010, Antimicrobial agents and chemotherapy,
B Pradines, and M Mabika Mamfoumbi, and D Parzy, and M Owono Medang, and C Lebeau, and J R Mourou Mbina, and J C Doury, and M Kombila
In vitro activity of pyronaridine against African strains of Plasmodium falciparum.
October 1992, Annals of tropical medicine and parasitology,
B Pradines, and M Mabika Mamfoumbi, and D Parzy, and M Owono Medang, and C Lebeau, and J R Mourou Mbina, and J C Doury, and M Kombila
Susceptibility of African isolates of Plasmodium falciparum to artemisinin (qinghaosu).
September 1992, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit (GTZ),
B Pradines, and M Mabika Mamfoumbi, and D Parzy, and M Owono Medang, and C Lebeau, and J R Mourou Mbina, and J C Doury, and M Kombila
Decreasing chloroquine resistance in Plasmodium falciparum isolates from Gabon.
January 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene,
B Pradines, and M Mabika Mamfoumbi, and D Parzy, and M Owono Medang, and C Lebeau, and J R Mourou Mbina, and J C Doury, and M Kombila
In vitro susceptibility of Plasmodium falciparum isolates from Myanmar to antimalarial drugs.
November 2001, The American journal of tropical medicine and hygiene,
Copied contents to your clipboard!